# Cohorte Nationale VIH-2

> **NCT04658329** · — · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 1185 (estimated)

## Conditions studied

- HIV-2 Infection

## Interventions

- **DRUG:** Antiretroviral

## Key facts

- **NCT ID:** NCT04658329
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1994-01-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 1185 (ESTIMATED)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04658329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04658329, "Cohorte Nationale VIH-2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04658329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*